Cooperative Interactions of HER-2, HPV-16 Oncoproteins in the Malignant Transformation of Human Mammary Epithelial Cells

• Main Authors: Kathleen M. Woods Ignatoski, Michele L. Dziubinski, Cheryl Ammerman, Stephen P. Ethier
• Format: Article
• Language: English
• Published: Elsevier 2005-08-01
• Series: Neoplasia: An International Journal for Oncology Research
• Subjects: Her-2; HPV E6; HPV E7; EGFR; human breast cancer
• Online Access: http://www.sciencedirect.com/science/article/pii/S1476558605801113
• ISSN: 1476-5586; 1522-8002

To better underst, the mechanisms of transformation by the oncogene HER-2, we transduced the human mammary epithelial (HME) cell line MCF-10A with HER-2, developed a cell line that appeared to moderately overexpress HER-2. These MCF-10HER-2 cells were unable to grow in the absence of epidermal growth factor (EGF). However, coexpression of HER-2 with the HPV-16 oncoproteins E6, E7 resulted in EGF-independent cells that expressed very high levels of constitutively activated HER-2. Interestingly, coexpression of E7 with HER-2 resulted in cells that were EGF-independent for growth but did not express HER-2 to high levels, coexpression of E6 with HER-2 resulted in cells expressing higher levels of HER-2, which were still dependent on EGF for growth, survival. The MCF-10HER-2E7, HER-2/ E6E7 cells exhibited constitutive activation of a form of epidermal growth factor receptor (EGFR) that had a faster electrophoretic mobility than EGFR activated by exogenous growth factors. Exposure of cells with EGFR activation to ZD1839 (Iressa), at concentrations specific for EGFR, had little or no influence on proliferation of cells with amplified HER-2 but little or no EGFR. These results indicate that HER-2, E6, E7 cooperate with endogenous EGFR to yield fully transformed cells.